Hepatocellular Carcinoma
Conditions
Brief summary
This is an ongoing, longitudinal, single centre, observational, retro-prospective clinical cohort study of patients with HCC in usual clinical practice. All the HCC patients diagnosed and treated in Liver Cancer Center, Nanfang Hospital are consecutively collected and followed up.
Interventions
OTHERNo intervention
Sponsors
Nanfang Hospital, Southern Medical University
Study design
Observational model
COHORT
Time perspective
OTHER
Eligibility
Sex/Gender
ALL
Age
16 Years to No maximum
Healthy volunteers
No
Inclusion criteria
* Clinical diagnosis of HCC; * Age ≥ 16 years; * Received treatment targeting for HCC at least once, including operation, ablation, TACE, sorafenib, radiotherapy, chemotherapy, etc; * Good compliance with clinical treatment.
Exclusion criteria
* Diagnosed as other pathological types such as cholangiocarcinoma, or mixed liver cancer; * Received only traditional Chinese medicine or symptomatic supportive treatment; (3) survival time ≤ 7 days; * HCC diagnosed after liver transplantation; * Poor compliance or important data deficient.
Design outcomes
Primary
| Measure | Time frame | Description |
|---|---|---|
| Evaluate the overall survival rate of all HCC patients | 10 years | In order to identify the potential influence factors of HCC patients survival |
| Evaluate the recurrence free survival rate of HCC patients after curative treatments | 10 years | In order to identify the potential influence factors of tumor recurrence |
Countries
China
Contacts
Primary ContactJinlin Hou
Outcome results
None listed